• No results found

Neurologic disease

Genetic testing utilization for patients with neurologic disease and the limitations of claims data

Genetic testing utilization for patients with neurologic disease and the limitations of claims data

... with neurologic disease on a population- wide scale, although we found that it is extremely difficult to evaluate the utilization of genetic testing in a modern claims database because of the nonspecificity of ...

5

Infection of Immunodeficient Horses with Sarcocystis neurona Does Not Result in Neurologic Disease

Infection of Immunodeficient Horses with Sarcocystis neurona Does Not Result in Neurologic Disease

... It is possible that the lack of neurovirulence in SCID horses is a result of either protective innate immune responses or a requirement for adaptive immune responses in the pathogen- esis of neurologic ...

6

A new way to estimate neurologic disease prevalence in the United StatesIllustrated with MS

A new way to estimate neurologic disease prevalence in the United StatesIllustrated with MS

... gressive neurologic disease of young adults, 1,2 affecting indi- viduals in their most productive years, and placing a heavy burden on affected persons, their family members, and the health care ...

13

Delayed Primary HHV-7 Infection and Neurologic Disease

Delayed Primary HHV-7 Infection and Neurologic Disease

... had neurologic disease aged younger than 18 years seen at the Hospital for Sick Children, Toronto, Canada, between April 1, 1998 and December 31, 2011, whose cerebrospinal fl uid (CSF) was found by ...

9

Risk of Serious Neurologic Disease After Immunization of Young Children in Britain and Ireland

Risk of Serious Neurologic Disease After Immunization of Young Children in Britain and Ireland

... 157 disease episodes from 155 children met the analytical case ...serious neurologic disease in any of the specified risk periods with the exception of a raised relative incidence of ...

10

ABCA7 loss-of-function variants, expression, and neurologic disease risk

ABCA7 loss-of-function variants, expression, and neurologic disease risk

... (A) ABCA7 messenger RNA (mRNA) and (B) protein isolated from human brain tissue (temporal cortex) were assessed using quantitative PCR and Western blot, respectively, for carriers and noncarriers (nc) of the 3 most ...

9

Toxoplasmosis: A Treatable Neurologic Disease in the Immunologically Compromised Patient

Toxoplasmosis: A Treatable Neurologic Disease in the Immunologically Compromised Patient

... Neurologic examination showed a mild right- sided hemiparesis, and on computed tomography (CT) scan a left parietal lucency with ring enhancement on contrast injection was seen (Fig 1)..[r] ...

5

Clinical NMR Imaging of the Brain in Children: Normal and Neurologic Disease

Clinical NMR Imaging of the Brain in Children: Normal and Neurologic Disease

... The brain appears relatively featureless , except that in an infant of 31 weeks gestation examined at 5 weeks of age 36 weeks PMA and in one full-term infant examined at 2 weeks of age 4[r] ...

14

Dihydropteridine Reductase Deficiency Associated With Severe Neurologic Disease and Mild Hyperphenylalaninemia

Dihydropteridine Reductase Deficiency Associated With Severe Neurologic Disease and Mild Hyperphenylalaninemia

... per day in combination with carbidopa, a peniph- eral aromatic amino acid decarboxylase inhibitor, at a dosage of 2.5 mg per kilogram of body weight. per day; both were given in two divi[r] ...

8

Biallelic TOR1A variants in an infant with severe arthrogryposis

Biallelic TOR1A variants in an infant with severe arthrogryposis

... (A) Pedigree—the proband is the first child born to his parents and is designated by the arrow. The family history is unremarkable for symptoms of arthrogryposis or DYT1 dystonia; however, there is a paternal aunt and ...

5

Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease

Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease

... Lyme disease patients ( n 5 13) had been diagnosed and had completed a course of antibiotic treatment for their infection a mini- mum of 6 mo before ...Other neurologic disease (OND) controls ( n 5 ...

6

Natural Progression of Neurological Disease in Mucopolysaccharidosis Type II

Natural Progression of Neurological Disease in Mucopolysaccharidosis Type II

... OBJECTIVE: Mucopolysaccharidosis type II (MPS II) is a lysosomal stor- age disorder characterized by insufficiency of the iduronate-2- sulfatase enzyme, which results in excess heparan and dermatan sul- fates within the ...

10

Infant Botulism: Clinical Spectrum and Epidemiology

Infant Botulism: Clinical Spectrum and Epidemiology

... Between 1977 and 1979, 12 cases of infant botulism were diagnosed in Utah, and 87 control patients (normal, nonbotulism neurologic disease, and nonbotul-.. ism systemic disease) were eva[r] ...

9

Protective Role of the Virus-Specific Immune Response for Development of Severe Neurologic Signs in Simian Immunodeficiency Virus-Infected Macaques

Protective Role of the Virus-Specific Immune Response for Development of Severe Neurologic Signs in Simian Immunodeficiency Virus-Infected Macaques

... multiple neurologic complications collectively defined as AIDS dementia complex (ADC) ...induced neurologic disease has remained a topic of controversy (6, ...patients neurologic symptoms ...

8

Comparative evaluation of a novel, moderately hypofractionated radiation protocol in 56 dogs with symptomatic intracranial neoplasia

Comparative evaluation of a novel, moderately hypofractionated radiation protocol in 56 dogs with symptomatic intracranial neoplasia

... logic disease have a different outcome upon treatment has not been shown to ...of neurologic disease (P = ...of neurologic disease where we therefore assumed radiation to have had a ...

8

International Education Issues: Neurology and poverty

International Education Issues: Neurology and poverty

... for neurologic disorders in LAMI countries are ...of neurologic disease, 2) lack of access to essential medications, 3) paucity of epi- demiologic research available, 4) reduced ratio of ...

5

Neurologic Wilson’s Disease and its Management - An Update

Neurologic Wilson’s Disease and its Management - An Update

... Wilson’s disease is an autosomal recessive disease that occurs when a patient carries mutations in both copies of his/her ATP7B ...of disease-causing mutations, most patients are compound ...

12

Child Neurology: Primary angiitis of the CNS

Child Neurology: Primary angiitis of the CNS

... The patient then presented to the Partners Pediat- ric MS Center at Massachusetts General Hospital. She complained of fatigue and intermittent headaches but had no further seizures and neurologic examina- tion was ...

5

Successful resolution of stromal keratitis and uveitis using canakinumab in a patient with chronic infantile neurologic, cutaneous, and articular syndrome: a case study

Successful resolution of stromal keratitis and uveitis using canakinumab in a patient with chronic infantile neurologic, cutaneous, and articular syndrome: a case study

... A 64-year-old female was referred to our department for the treatment of an infectious corneal ulcer. She re- ported experiencing daily episodes of urticaria-like rashes, fevers, and arthralgia since birth. She also had ...

5

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

... for neurologic Lyme disease promoted by IDSA, anti- biotic therapy ranging from 6 months to more than 5 years is recommended by infectious disease experts for a number of conditions, including ...

8

Show all 10000 documents...

Related subjects